乳腺叶状肿瘤:采用改良德尔菲法的加拿大全国共识文件
针对乳腺叶状肿瘤前瞻性数据有限、治疗异质性的问题,采用改良德尔菲法纳入加拿大患者和从业人员制定全国共识声明。基于文献回顾制定声明,经两轮调查和虚拟共识会议,23名参与者批准了100条关于诊断、病理、手术规划、辅助治疗、复发、监测和患者支持的声明,共识阈值定义为≥80%。交界性叶状肿瘤的管理存在不确定性,相关推荐反映了该罕见情况证据的缺乏。
要点
- 共识声明涵盖诊断、病理、手术规划、辅助治疗、复发、监测和患者支持,以≥80%同意为阈值批准。
- 交界性叶状肿瘤的管理是共识中的不确定领域,相关推荐反映证据缺乏。
- 共识文件旨在指导实践和未来研究。
核心结论
- 制定了包含所有已批准声明的叶状肿瘤诊疗共识文件,以帮助指导实践和未来研究。
研究设计与样本
- 采用改良德尔菲法制定全国共识,基于文献回顾形成声明,经两轮调查和计划中的虚拟共识会议,从外科、放射肿瘤科、肿瘤内科、病理科、放射科和整形外科邀请专家,23名参与者参会。
诊断标准与关键数值
- 100条关于诊断、病理、手术规划、辅助治疗、复发、监测和患者支持的声明以预先定义的≥80%共识获得批准,并制定和批准了两张关于局部区域管理的表格。
临床应用与阅片要点
- 共识文件可作为叶状肿瘤诊疗实践的参考;交界性叶状肿瘤的管理存在不确定性,相关推荐反映证据缺乏。
局限性
- 叶状肿瘤罕见,前瞻性数据有限。
- 交界性叶状肿瘤的管理是 uncertainty 的来源,相关推荐反映证据缺乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Phyllodes tumors are rare breast neoplasms with limited prospective data to guide treatment, leading to heterogeneous management of this disease. We developed National consensus statements using modified Delphi methodology including patients and practitioners across Canada.
METHODS: Statements were developed based on a literature review. Two iterations of surveys were distributed with a planned virtual consensus meeting. Panelists were invited from surgery, radiation oncology, medical oncology, pathology, radiology, and plastic surgery.
RESULTS: Twenty-three participants attended the virtual conference. One hundred statements regarding diagnostics, pathology, surgical planning, adjuvant therapies, recurrence, surveillance, and patient support were approved with an a priori defined consensus of ≥ 80%. Two tables on locoregional management were developed and approved. The management of borderline phyllodes tumors was a source of uncertainty, and recommendations reflect the lack of evidence in this rare presentation.
CONCLUSION: A consensus document containing all approved statements for the care and management of phyllodes tumors was developed to help guide practice and future research.
引用
- Bogach J, Sriskandarajah A, Wright FC, et al. Phyllodes Tumors of the Breast: Canadian National Consensus Document Using Modified Delphi Methodology. Ann Surg Oncol. 2023. PMID: 37556009. doi:10.1245/s10434-023-13912-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。